The U.S. Food and Drug Administration (FDA) has approved monthly maintenance dosing for Leqembi (lecanemab), a treatment for early Alzheimer’s disease.

On October 14, 2024, the FDA approved a 320-mg single dose of bimekizumab-bkzx (Bimzelx; UCB) in a 2-mL prefilled syringe and autoinjector; both forms are now commercially available in the US.

Novo Nordisk defended its next-generation obesity drug candidate CagriSema on Wednesday following late-stage trial data ...

Available Ozempic alternatives: Mounjaro, Victoza, Metformin, Saxenda, Wegovy ... but in a slightly higher dose. However, unlike Ozempic, Wegovy is FDA approved for weight management in adults ...

Engerix-B is also offered as a four-dose series for adults who are undergoing hemodialysis (kidney dialysis). The current recommended hepatitis B vaccine schedule for adults who have not previously ...

NRL legend Mark ‘MG’ Geyer, who was let go from Triple M after 17 years on air, has landed a new high profile radio gig. Geyer has signed a three year deal with 2GB radio in Sydney ...

President-elect Donald Trump will be sworn in as the 47th president on Monday, as weather forces the ceremony at the Capitol to move indoors—with billionaires and ex-presidents among those on ...

Pep Guardiola's side may not be in crisis mode right now, but Wednesday's game will answer the question of if their previous woes are behind them or if the schedule just gave them a brief reprieve.

Read More About MG MG4 MG's most popular car gets powerful hybrid makeover: 2025 MG ZS revealed ahead of imminent Australian release for Toyota Corolla Cross and GWM Haval Jolion rival MG stuns with ...

Get set for a much-changed Formula 1 grid in 2025 as the final season of the sport's current rules era gets set for another 24-race tour around the world, all live on Sky Sports F1. Next season's ...

And then there was one. The NFL has dominated just about every day of the week this year, with Tuesday being the only one that didn't make the cut. As we inch closer to the season's conclusion ...

In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is rolling out new data on a higher-dose injection in obesity. In the phase 3b ...